COMMONWEALTH OF AUSTRALIA
Department of Health
Therapeutic Goods Administration
THERAPEUTIC GOODS ACT 1989
Sections 14 and 14A Notice
On 17 November 2015, a delegate of the Secretary of the Department of Health, on the application of Pfizer Australia, consented under sections 14 and 14A of the Therapeutic Goods Act 1989 (the Act) to the supply of
Product name | ARTG number |
Centrum for Women | AUST L 200414 |
Centrum for Women 50+ | AUST L 211922 |
Centrum Specialist Cardio Plus | AUST L 224683 |
Centrum Specialist Energy Plus | AUST L 224847 |
Centrum Specialist Vision Plus | AUST L 224881 |
that do not conform with the requirements of the subclause 3(2)(g) of the Therapeutic Goods Order No. 69 – General requirements for labels for medicines, in that the formatting of the warning statements is different to the requirements of MASS 2014, which requires some of the statements to be included at the beginning of the directions for use on the label.
The consent is effective from 17 November 2015 until 31 March 2017.